Phibro Animal Health reported $539.7M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Align Technology USD 212.24M 2.7M Jun/2026
ANI Pharmaceuticals USD 143.15M 319K Jun/2026
Aurora Cannabis CAD 175.08M 55.48M Mar/2026
Bristol-Myers Squibb USD 2.74B 19M Jun/2026
Canopy Growth CAD 110.51M 4.96M Mar/2026
Corcept Therapeutics USD 13.18M 295K Jun/2026
Eli Lilly USD 16.79B 2.26B Jun/2026
Henry Schein USD 2.06B 45M Jun/2026
Idexx Laboratories USD 391.58M 9.18M Jun/2026
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Merck USD 6.21B 272M Jun/2026
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Pacira USD 134.57M 15.8M Jun/2026
Phibro Animal Health USD 539.7M 22.35M Mar/2026
Prestige Brands USD 190.22M 31.08M Jun/2026
Supernus Pharmaceuticals USD 107.03M 3.74M Jun/2026
Zoetis USD 2.57B 24M Jun/2026